Using the polymerase chain reaction ("PCR") to ... for use in the production of mRNA therapeutics; and (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services.

Using the polymerase chain reaction ("PCR") to ... for use in the production of mRNA therapeutics; and (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services.

LTRN A May 5 th  press release indicated that the FDA cleared Lantern Pharma, Inc.’s (NASDAQ:LTRN) LP-184 trial in triple ...

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction ... I and Clade Ib in addition to Clade II- STONY BROOK, NY / ACCESSWIRE / August ...

DNA methylation is involved in normal cellular ... miRNAs are encoded in our genome and are generally transcribed by RNA polymerase II. Despite the growing evidence for their importance in normal ...

First Trial Site Initiated for Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer - On May 8, 2025, the Company announced initiation of the first trial site for the OVATION ...

Doctors have long believed that this drug works by damaging the building blocks of DNA. However ... at other institutions to run a Phase II or III clinical trial in which patients receive the ...

Beads were washed three times with wash buffer II (50 mM Tris-HCl (pH 7.8), 50 mM NaCl ... The resulting cDNAs were PCR-amplified using LA Taq DNA polymerase (TaKaRa), a common PCR primer used for all ...